文献速递肝病

时空与单细胞转录组揭示CD226-NECTIN2在胆管炎症中的作用

Temporal assessment of spatial and single-cell transcriptomes identifies CD226-NECTIN2 T cell-cholangiocyte interaction in bile duct inflammation.
PubMed 文献 · J Hepatol · 2026-10-05

该研究对NOD.c3c4小鼠10、20、40周龄肝脏进行空间转录组和单细胞转录组分析,发现CD226-NECTIN2是T细胞与胆管细胞间的关键相互作用。体外敲低Nectin2及体内抗CD226阻断可减少T细胞活化,人PSC、PBC和ALD肝标本中验证了该相互作用在炎症胆管处的共定位。

要点

  • 空间转录组可区分NOD.c3c4小鼠炎症与非炎症肝区。
  • CD226-NECTIN2介导T细胞与胆管细胞相互作用。
  • 阻断CD226-NECTIN2可减少T细胞活化,人肝标本验证共定位。

核心结论

  • CD226-NECTIN2 T细胞-胆管细胞相互作用在胆管炎症中被识别、功能验证并在人类疾病中检测到,可能成为未来治疗靶点。

研究设计与样本

  • 研究使用10、20和40周龄雄性NOD.c3c4小鼠肝脏进行空间转录组学和单细胞RNA测序(scRNA-seq)。
  • 差异表达基因通过CellphoneDB数据库分析,重点关注T细胞相关相互作用。
  • CD226-NECTIN2相互作用通过共培养实验和小鼠抗体治疗验证,并在人PSC、PBC和ALD肝标本中分析。

主要发现

  • 空间转录组学在不同年龄NOD.c3c4小鼠中一致区分炎症和非炎症肝区。
  • 结合富集免疫细胞和胆管细胞的scRNA-seq,关键炎症细胞类型定位到胆管结构。
  • 通过差异表达基因和CellphoneDB分析发现CD226-NECTIN2 T细胞-胆管细胞相互作用。
  • 体外敲低Nectin2和NOD.c3c4小鼠中抗CD226阻断特异性减少T细胞活化。
  • 人类患病肝脏显示炎症胆管处一致的CD226-NECTIN2共定位。

临床怎么用

  • CD226-NECTIN2相互作用可作为PSC等胆管炎症疾病的潜在治疗靶点。
  • 空间转录组联合scRNA-seq流程可用于识别疾病相关基因和相互作用伙伴。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC) are inflammatory bile duct disorders affecting mostly young adults that often lead to liver cirrhosis and cancer. Especially for PSC, pathogenic mechanisms remain unclear and treatment options are lacking. To better understand biliary disease processes in bile duct inflammation, we analyzed livers of NOD.c3c4 mice by spatial and single-cell (scRNA-seq) transcriptomics, identifying key cell types, interactions and potential changes over time that were validated in human liver explants. METHODS: Livers of 10, 20 and 40-week-old male NOD.c3c4 mice were used for spatial transcriptomics and scRNA-seq. Differentially-expressed genes at different time points were analyzed using the CellphoneDB database with a focus on T cell-related interactions. CD226-NECTIN2 interaction was validated using co-culture experiments and antibody treatment in NOD.c3c4 mice. CD226-NECTIN2 in PSC, PBC and alcohol-related liver disease (ALD) explants was analyzed by spatial transcriptomics and immunofluorescence. RESULTS: Spatial transcriptomics consistently distinguished inflamed and non-inflamed liver areas in NOD.c3c4 mice at different ages. When combined with scRNA-seq enriched for immune cells and cholangiocytes, key inflammatory cell types were localized to biliary structures. Using differentially-expressed genes and a curated overview of biologically-validated interactions (CellphoneDB), the CD226-NECTIN2 T cell-cholangiocyte interaction was discovered. Knock-down of Nectin2 in vitro and anti-CD226 blocking in NOD.c3c4 mice specifically reduced T cell activation and diseased human liver showed consistent CD226-NECTIN2 co-localization at inflamed bile ducts. CONCLUSIONS: By combining spatial transcriptomics and scRNA-seq in NOD.c3c4 mice, we generated a pipeline for in-depth identification of potential disease relevant genes and interaction partners. The T cell-cholangiocyte interaction CD226-NECTIN2 was identified, functionally validated and detected in human disease highlighting this interaction as a possible future treatment target. IMPACT AND IMPLICATIONS: PSC is an intractable immune-mediated cholestatic liver disease that mainly affects young people and has a significant impact on families and the healthcare system due to treatment costs and sick leave. Our study aimed to find new ways of understanding PSC and highlight potential treatment targets by first identifying disease-relevant cell interactions in a mouse model, followed by confirmation in human PSC livers.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Jördens MS, Nordhus KS, Øgaard J, et al. Temporal assessment of spatial and single-cell transcriptomes identifies CD226-NECTIN2 T cell-cholangiocyte interaction in bile duct inflammation. J Hepatol. 2026. PMID: 42833310. doi:10.1016/j.jhep.2026.09.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。